| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 334474 | Psychiatry Research: Neuroimaging | 2013 | 4 Pages |
Abstract
We hypothesized that atomoxetine (ATMX) would produce similar brain effects in attention-deficit/hyperactivity disorder (ADHD) as those of methylphenidate (MPH). Eleven ADHD adults performed the Multi-Source Interference Task (MSIT) during functional magnetic resonance imaging (fMRI) at baseline and after 6weeks of ATMX treatment. ATMX was associated with increased fMRI activation of dorsolateral prefrontal cortex, parietal cortex and cerebellum but not dorsal anterior midcingulate cortex (daMCC). These results suggest that ATMX and MPH have similar but not identical brain effects.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
George Bush, Jennifer Holmes, Lisa M. Shin, Craig Surman, Nikos Makris, Eric Mick, Larry J. Seidman, Joseph Biederman,